iCardiac Technologies CEO and leadership

Wojciech Zareba, MD, PhD, is a Professor of Medicine (Cardiology), Director of Cardiology Clinical Research, and Director of the Heart Research Follow Up Program at University of Rochester Medical Center, Rochester, NY. Dr. Zareba is Principal Investigator on several NIH and corporate grants focused on risk stratification of cardiac death, ICD patients, and on clinical usefulness and prognostic significance of ECG parameters (recent trials with the role as PI: RAID, TEMPO, LQT3 Pivotal trial) . He also serves as Principal Investigator of the ECG Core Labs for numerous studies including the International LQTS Registry, the North American ARVD Registry, MADIT II, and MADIT-CRT, large clinical trials testing clinical effectiveness and safety of implantable cardiac defibrillators and resynchronization devices. He participated in a number of corporate research projects focused on evaluating drug safety and participated in a number of advisory councils on the topic of cardiac safety in drug trials. Dr Zareba has authored or co-authored more that 500 publications in cardiology research with many of them focused on sudden death, risk stratification, QT prolongation, and ECG related cardiac safety biomarkers. Dr. Zareba is Past President of the International Society for Holter and Noninvasive Electrocardiology and President Elect of the International Society of Electrocardiology. Dr. Zareba is the Past Editor in Chief of Cardiology Journal, and since 2012 Editor of the Annals of Noninvasive Electrocardiology as well as a member of the editorial boards of a number of other leading cardiology-related journals.

Specialties: cardiac safety, QT prolongation, cardiac arrhythmias, clincal trials

Jay served as Chief Financial Officer for iCardiac Technologies from the founding of the company in 2006 to its sale to ERT in 2017.

He was responsible for all finance and human resources operations of the company. Jay also oversaw iCardiac’s logistical operations which supported thousands of clinical trial sites globally.

Before joining the team at iCardiac, Jay served as Controller at Lenel Systems. He worked at Lenel from 1996, when the company had less than $1 million in revenues, up until its sale in 2005 to UTC. By then Lenel had reached $100 million in run-rate revenues.

Jean-Philippe Couderc is the Co-founder and CEO at VPG Medical Inc. Jean attended University of Rochester - Simon Business School.